Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

  • your selections
Clear Search

Filter Results

date

Topics

Tags

Content Type

  • results
  • state & global data
  • slides
The Henry J. Kaiser Family Foundation

Health Costs

Topic Landing Page Read More
EHBS Graphing Tool Premiums and Worker Contributions 337x251

Premiums and Worker Contributions Among Workers Covered by Employer-Sponsored Coverage, 1999-2014

This graphing tool allows users to explore trends in workplace-sponsored health insurance premiums and worker contributions over time for different categories of employers based on results from the annual Employer Health Benefits Survey. Breakouts are available by firm size, region and industry, as well as for firms with relatively few or many part-time workers, higher- or lower-wage workers, and older or younger workers.

Interactive Read More
ehbs_2014_bar

Web Briefing for Media: 2014 Kaiser/HRET Employer Health Benefits Survey

On Wednesday, September 10, 2014, the Kaiser Family Foundation and the Health Research & Educational Trust (HRET) held a reporters-only web briefing to release the 2014 Employer Health Benefits Survey.

Event Read More
The Henry J. Kaiser Family Foundation

Drew Altman: 3 Takeaways From the Medicare Trustees Report

In his latest column for The Wall Street Journal’s Think Tank, Drew Altman dives into this week’s release of the Social Security and Medicare Trustees Report to discuss the good news that may have been missed. All previous columns by Drew Altman are available online.

News Release Read More
The Henry J. Kaiser Family Foundation

3 Takeaways From the Medicare Trustees Report

In his latest column for The Wall Street Journal’s Think Tank, Drew Altman dives into this week’s release of the Social Security and Medicare Trustees Report to discuss the good news that may have been missed.

Perspective Read More
The Henry J. Kaiser Family Foundation

New Analysis Highlights Variations and Trends in Medicare Beneficiaries’ Out-of-Pocket Spending

A new Kaiser Family Foundation analysis and chartbook break down what beneficiaries with traditional Medicare pay for their health care, including insurance premiums, and costs for medical and long-term care services. The analysis highlights the significant variations in what people pay based on the services they use, and their age,…

News Release Read More
The Henry J. Kaiser Family Foundation

How Much Is Enough? Out-of-Pocket Spending Among Medicare Beneficiaries: A Chartbook

This new analysis and chartbook examines out-of-pocket spending among Medicare beneficiaries, including spending on health and long-term care services and insurance premiums, using the most current year of data available from a nationally representative survey of people on Medicare. It explores which types of services account for a relatively large share of out-of-pocket spending, which groups of beneficiaries (including by age, gender, health status, and chronic conditions) are especially hard hit by high out-of-pocket costs, and trends in out-of-pocket spending between 2000 and 2010.

Report Read More
The Henry J. Kaiser Family Foundation

Medicaid Spending Growth in the Great Recession and Its Aftermath, FY 2007-2012

This report presents data on changes in Medicaid’s enrollment and spending between federal fiscal year 2007 and federal fiscal year 2012, a period which includes the worst economic downturn in the United States since the Great Depression. The paper also examines what factors drove Medicaid spending over the period, and concludes that overall spending growth from 2007 to 2012 was driven largely by the enrollment growth that resulted from many people losing jobs and income during the recession. However, on a per enrollee basis, Medicaid spending has grown more slowly than other sectors of the health system.

Issue Brief Read More
The Henry J. Kaiser Family Foundation

Health Affairs Blog: The Cost of A Cure: Medicare’s Role in Treating Hepatitis C

This blog post discusses Sovaldi (sofosbuvir), an oral drug recently approved by the FDA for the treatment of chronic hepatitis C, and the potential impact of this long-awaited cure on Medicare spending and Part D premiums.

Perspective Read More